besifloxacin 0.6 % Ophthalmic Suspension

RxCUI: 850305
RxNorm name: besifloxacin 0.6 % Ophthalmic Suspension
Display name: besifloxacin 0.6 % Ophthalmic Suspension
Full name: besifloxacin 0.6 % Ophthalmic Suspension
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:12

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Besivance	BESIFLOXACIN	Sportpharm LLC	80bf4981-4f86-4d25-83a5-7d5dfe0b22e0	2026-07-23	Warnings, Adverse reactions	Exact identifier rxcui: 850305
Besivance	BESIFLOXACIN	Bausch & Lomb Incorporated	a3e6d688-7e5e-4ca3-b27e-79756c322a32	2024-07-03	Warnings, Adverse reactions	Exact identifier rxcui: 850305

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
a3e6d688-7e5e-4ca3-b27e-79756c322a32	besifloxacin 0.6 % Ophthalmic Suspension [PSN] · besifloxacin 6 MG/ML Ophthalmic Suspension [SCD] · besifloxacin 0.6 % Ophthalmic Suspension [SY]	3	20	These highlights do not include all the information needed to use BESIVANCE safely and effectively. See full prescribing information for BESIVANCE. BESIVANCE ® (besifloxacin ophthalmic suspension), for topical ophthalmic use Initial U.S. Approval: 2009	20240703
c326263e-4b55-41b6-b862-c970668669ec	besifloxacin 0.6 % Ophthalmic Suspension [PSN] · besifloxacin 6 MG/ML Ophthalmic Suspension [SCD] · besifloxacin 0.6 % Ophthalmic Suspension [SY]	3	1	These highlights do not include all the information needed to use Besivance safely and effectively. See full prescribing information for Besivance. Besivance TM (besifloxacin ophthalmic suspension) 0.6% Sterile topical ophthalmic drops Initial U.S. Approval: 2009	20090401